by Angela L. Huang | Mar 15, 2023 | News
SAN FRANCISCO, CA —Tempo Bioscience, Inc. (“Tempo”) a privately-held biotechnology company based in San Francisco, California, has released new human induced pluripotent stem cell (iPSC) derived cell products and affiliated cell-based services in the following...
by Angela L. Huang | Oct 19, 2022 | News
SAN FRANCISCO, CA —Tempo Bioscience, Inc. (“Tempo”) a privately-held biotechnology company based in San Francisco, California, has released new human induced pluripotent stem cell (iPSC) derived cell products and affiliated cell-based services in the following...
by Angela L. Huang | Apr 10, 2019 | News
SAN FRANCISCO, CA —Tempo Bioscience, Inc. (“Tempo”) a privately-held biotechnology company based in San Francisco, California, has released new human induced pluripotent stem cell (iPSC) derived products and affiliated cell-based services in the following categories:...
by Angela L. Huang | Nov 13, 2016 | Industry News
Recently, Cell Symposia celebrated the 10-year anniversary of the seminal publication on inducible pluripotent stem cells (iPSCs). An audience of scientists from academia, biotech and pharma gathered to celebrate Drs. Yamanaka and Takahashi’s work and to discuss...
